feed,title,long_url,short_url
Benzinga,"Halliburton Clocks 29.7% Revenue Growth In Q3, Misses Consensus",https://benzinga.com/news/earnings/21/10/23442506/halliburton-clocks-29-7-revenue-growth-in-q3-misses-consensus,https://j.mp/3pw7YVd
Benzinga,Enanta Plans To Start Human Trials For Its COVID-19 Candidate In 2022,https://benzinga.com/general/biotech/21/10/23438986/enanta-plans-to-start-human-trials-for-its-covid-19-candidate-in-2022,https://j.mp/3DYkBfI
Benzinga,Daily Infographic: Vehicles On the Road,https://benzinga.com/news/21/10/23438199/daily-infographic-vehicles-on-the-road,https://j.mp/3vrtafF
Benzinga,Dicerna Posts Mixed Nedosiran Data In Rare Kidney Disease Trial,https://benzinga.com/general/biotech/21/10/23438780/dicerna-posts-mixed-nedosiran-data-in-rare-kidney-disease-trial,https://j.mp/3lWXxaE
